{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:20Z","timestamp":1792478600936,"version":"4.5.0"},"reference-count":30,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15858","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:51:41Z","timestamp":1789361501000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent EGFR exon 19 deletion\u2011insertion and germline BRCA1 alteration in KRAS\u2011wild\u2011type pancreatic ductal adenocarcinoma: A case report and review of therapeutic implications"],"prefix":"10.3892","volume":"32","author":[{"given":"Sheng","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Oncology, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, Hubei 443000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, Hubei 443000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, Hubei 443000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"key20261020093212_b1-ol-32-5-15858","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"key20261020093212_b2-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin Oncol"},{"key":"key20261020093212_b3-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol Res"},{"key":"key20261020093212_b4-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov"},{"key":"key20261020093212_b5-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","article-title":"Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival","volume":"31","author":"Varghese","year":"2025","journal-title":"Nat Med"},{"key":"key20261020093212_b6-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers (Basel)"},{"key":"key20261020093212_b7-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"key20261020093212_b8-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"17588359241290482","DOI":"10.1177\/17588359241290482","article-title":"Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX","volume":"16","author":"Kim","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"key20261020093212_b9-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.2147\/CMAR.S211151","article-title":"BRCA mutations in pancreas cancer: Spectrum, current management, challenges and future prospects","volume":"12","author":"Wong","year":"2020","journal-title":"Cancer Manag Res"},{"key":"key20261020093212_b10-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"e35666","DOI":"10.1002\/cncr.35666","article-title":"The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation","volume":"131","author":"Katona","year":"2025","journal-title":"Cancer"},{"key":"key20261020093212_b11-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00432-018-2666-9","article-title":"Emerging strategies in BRCA-positive pancreatic cancer","volume":"144","author":"Kowalewski","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20261020093212_b12-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/ijc.30650","article-title":"Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients: Clinical value of ctDNA in metastatic pancreatic cancer","volume":"140","author":"Cheng","year":"2017","journal-title":"Int J Cancer"},{"key":"key20261020093212_b13-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"1427802","DOI":"10.3389\/fonc.2024.1427802","article-title":"Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer","volume":"14","author":"Mustafa","year":"2024","journal-title":"Front Oncol"},{"key":"key20261020093212_b14-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"a031435","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The critical driver and therapeutic target for pancreatic cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20261020093212_b15-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"111048","DOI":"10.1016\/j.ygeno.2025.111048","article-title":"Genomic mutation and clinicopathological features of KRAS wild-type tumors in Chinese cohort with pancreatic adenocarcinoma","volume":"117","author":"Ye","year":"2025","journal-title":"Genomics"},{"key":"key20261020093212_b16-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"403","DOI":"10.21037\/hbsn.2018.07.03","article-title":"Increased mutant KRAS gene dosage drives pancreatic cancer progression: Evidence for wild-type KRAS as a tumor suppressor?","volume":"7","author":"Kent","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20261020093212_b17-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"e2016904118","DOI":"10.1073\/pnas.2016904118","article-title":"Oncogenic KRAS engages an RSK1\/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer","volume":"118","author":"Cheng","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20261020093212_b18-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1080\/14796694.2024.2355078","article-title":"How to find a needle in a haystack: A systematic review on targeting KRAS wild-type pancreatic cancer","volume":"20","author":"Mouawad","year":"2024","journal-title":"Future Oncol"},{"key":"key20261020093212_b19-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J Clin Oncol"},{"key":"key20261020093212_b20-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1158\/1078-0432.CCR-20-1439","article-title":"A preclinical trial and molecularly annotated patient cohort identify predictive biomarkers in homologous recombination-deficient pancreatic cancer","volume":"26","author":"Wang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"key20261020093212_b21-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1200\/JCO.21.01604","article-title":"Overall survival results from the POLO trial: A phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer","volume":"40","author":"Kindler","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20261020093212_b22-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nature Commun"},{"key":"key20261020093212_b23-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5009\/gnl15465","article-title":"Systemic chemotherapy in advanced pancreatic cancer","volume":"10","author":"Lee","year":"2016","journal-title":"Gut Liver"},{"key":"key20261020093212_b24-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/biom11101469","article-title":"Recent advances in pancreatic cancer: Novel prognostic biomarkers and targeted therapy-a review of the literature","volume":"11","author":"Schlick","year":"2021","journal-title":"Biomolecules"},{"key":"key20261020093212_b25-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"1151178","DOI":"10.3389\/fonc.2023.1151178","article-title":"Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report","volume":"13","author":"Ma","year":"2023","journal-title":"Front Oncol"},{"key":"key20261020093212_b26-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"e2400132","DOI":"10.1200\/PO.24.00132","article-title":"Acquired EGFR resistance mutation C797S in pancreatic adenocarcinoma following partial response to Third-Generation EGFR inhibitor therapy","volume":"8","author":"Papa","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"key20261020093212_b27-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"key20261020093212_b28-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/tlcr-22-48","article-title":"A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: Different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"key20261020093212_b29-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.2147\/OTT.S328839","article-title":"Clinical and pathologic complete response to gefitinib in a patient with SqCLC harboring EGFR p.E746_S752delinsV mutation","volume":"14","author":"Zhuang","year":"2021","journal-title":"Onco Targets Ther"},{"key":"key20261020093212_b30-ol-32-5-15858","doi-asserted-by":"publisher","first-page":"e2200570","DOI":"10.1200\/PO.22.00570","article-title":"TP53 gain-of-function and non-gain-of-function mutations are associated with differential prognosis in advanced pancreatic ductal adenocarcinoma","volume":"7","author":"Pan","year":"2023","journal-title":"JCO Precis Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:18Z","timestamp":1792477938000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,14]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15858","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}